The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)

Clinical trial NCT01106690 · COMPLETED

Trial details

NCT number: NCT01106690
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-06-01
Primary completion: 2011-11-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.